Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Accounts Receivables · Q2 FY2024 · quarter ended Jun 2024
Accounts receivables outflow grows to $0
Q2 FY2024 accounts receivables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was $0. Over 3 fiscal years it compounded at -49.4% a year.
Context
- Accounts receivables amounted to 8.4% of revenue in FY2025, down 28.0 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 1.63M USD
- Year-over-year change
- +138.7%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.63M | +138.7% |
| FY2024 | 2024-12-31 | (4.2M) | -155.7% |
| FY2023 | 2023-12-31 | 7.54M | -39.9% |
| FY2022 | 2022-12-31 | 12.55M | +168.5% |
| FY2021 | 2021-12-31 | (18.31M) | — |
Accounts Receivables vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's LTM Jun 2024 accounts receivables of $0 is the 5th largest of the 10 companies compared; the peer median is $0.
- Accounts receivables amounts to 0.0% of revenue for SLGL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $692K | -37.7% | +75.9% | — | |
| LTM Mar 2026 | $117K | +103.5% | -41.7% | 0.1% | |
| FY2025 | $90.4K | -120.5% | — | — | |
| LTM Mar 2026 | $157.88 | -99.8% | — | 0.1% | |
| LTM Jun 2024 | $0 | — | -49.4% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding SLGL) | $0 | -68.7% | +17.1% | 0.0% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Depreciation & Amortization | 880K | 562K | 342K | 233K | 109K |
| Deferred Income Tax | (96K) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 687K | 1.53M | 1.86M | 786K | 0 |
| Change in Working Capital | (12.44M) | 3.54M | 7.67M | (4.4M) | 6.19M |
| Accounts Receivables | (18.31M) | 12.55M | 7.54M | (4.2M) | 1.63M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.62M | (8.3M) | 1.47M | 780K | 820K |
| Other Working Capital | 274K | (709K) | (1.34M) | (981K) | 3.75M |
| Other Non-Cash Items | 55K | (188K) | (361K) | 74K | 148K |
| Operating Cash Flow | (7.69M) | (9.48M) | (17.73M) | (13.89M) | 322K |
| Capital Expenditures | (143K) | (171K) | (134K) | (2K) | (47K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 54K |
| Purchases of Investments | (6.76M) | (10.01M) | (23.98M) | 0 | (14.08M) |
| Sales of Investments | 26.78M | 11.88M | 14.3M | 26.69M | 5.51M |
| Other Investing Activities | (5K) | 0 | 74K | 6K | (20K) |
| Investing Cash Flow | 19.87M | 1.7M | (9.74M) | 26.69M | (8.58M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 505K | 15K | 21.54M | 0 | 6K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 332K | 0 | 268K | 0 | 0 |
| Financing Cash Flow | 837K | 15K | 21.81M | 0 | 6K |
| Effect of Forex Changes | (55K) | 133K | (73K) | (1K) | (204K) |
| Net Change in Cash | 12.96M | (7.64M) | (5.74M) | 12.8M | (8.46M) |
| Free Cash Flow | (7.83M) | (9.66M) | (17.86M) | (13.89M) | 275K |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.